FDA to Review Restrictions on Popular Peptide Injections Amid Safety Concerns

Wed Apr 15 2026 15:57:02 GMT+0000 (Coordinated Universal Time)

The FDA is set to convene this summer to reconsider rules surrounding more than half a dozen unapproved peptide injections, often used by wellness influencers and athletes, amidst ongoing debates regarding their safety and efficacy.

The U.S. Food and Drug Administration (FDA) has announced an upcoming meeting to evaluate the safety and potential deregulation of seven peptide injections, a category of therapies largely unapproved for public use but favored by fitness enthusiasts and wellness influencers. This decision comes in response to pressure from Health Secretary Robert F. Kennedy Jr., who advocates for looser regulations on these substances, which are touted for their quick muscle-building and injury recovery properties despite a lack of substantial research backing their claims.

WASHINGTON (AP) — The Food and Drug Administration plans to hold a meeting this summer to potentially ease restrictions on over a handful of peptide injections, which have gained popularity among wellness advocates, fitness gurus, and celebrities. The FDA's move comes amid ongoing discussions about the safety and efficacy of these unapproved therapies, often marketed for building muscle and rejuvenating health.

The announcement on Wednesday follows repeated calls from Health Secretary Robert F. Kennedy Jr., who has promised to relax regulations on peptides. He claims to have personally benefited from their use for injury recovery, despite the FDA stating that most of these peptides remain untested for safety.

At the July meeting, the FDA's advisory panel will evaluate seven specific peptides to determine if they should be classified differently to allow for more widespread compounding by pharmacies. This group includes BPC-157, linked to claims of healing and inflammation reduction.

Earlier in 2023, the Biden administration contributed to restricting certain popular peptides from compounding pharmacies, which mix medications not readily available from drug manufacturers. The FDA had determined that many of these substances presented "significant safety risks."

In recent years, peptides have surged in popularity, partially fueled by the success of FDA-approved GLP-1 medications for obesity and diabetes. However, several of the peptides heavily marketed online remain unapproved and classified as illegal to promote as medical treatments.

Currently, wellness clinics offer these injections and IV infusions for high fees, while dietary supplement companies are advocating for regulatory changes that would allow the use of peptides in their products.

Kennedy, in an interview with Joe Rogan, expressed concerns over the FDA's restrictions, labeling them as illegal, and highlighting the grey market concerns regarding unverified products. He emphasized the need for assurance regarding the quality and safety of such substances amid rising illicit imports.